STAA

STAAR Surgical Company

STAA, USA

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

https://www.staar.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
STAA
stock
STAA

STAAR Surgical (NASDAQ:STAA) Shares Down 5.1% - What's Next? MarketBeat

Read more →
STAA
stock
STAA

STAAR Surgical (NASDAQ: STAA) investor Yunqi Capital urges no vote on Alcon deal Stock Titan

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$25.875

Analyst Picks

Strong Buy

3

Buy

0

Hold

10

Sell

0

Strong Sell

1

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

3.48

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

2.51 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

1.95 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

1.88 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.29

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 117.74% of the total shares of STAAR Surgical Company

1.

BROADWOOD CAPITAL Inc

(27.2829%)

since

2025/06/30

2.

BlackRock Inc

(14.8753%)

since

2025/06/30

3.

Vanguard Group Inc

(8.8607%)

since

2025/06/30

4.

Soleus Capital Management, L.P.

(6.0233%)

since

2025/06/30

5.

iShares Core S&P Small-Cap ETF

(5.9426%)

since

2025/08/31

6.

Armistice Capital, LLC

(5.6747%)

since

2025/06/30

7.

Resona Asset Management Co., Ltd.

(4.8874%)

since

2025/06/30

8.

Yunqi Capital Ltd

(4.8661%)

since

2025/06/30

9.

State Street Corp

(4.0419%)

since

2025/06/30

10.

Morgan Stanley - Brokerage Accounts

(2.6483%)

since

2025/06/30

11.

iShares Russell 2000 ETF

(2.4382%)

since

2025/08/31

12.

Geode Capital Management, LLC

(2.4072%)

since

2025/06/30

13.

Bank of America Corp

(2.3286%)

since

2025/06/30

14.

Vanguard Total Stock Mkt Idx Inv

(2.2838%)

since

2025/07/31

15.

Vanguard Small Cap Index

(1.6974%)

since

2025/07/31

16.

Palo Alto Investors, LLC

(1.598%)

since

2025/06/30

17.

Dimensional Fund Advisors, Inc.

(1.5853%)

since

2025/06/30

18.

American Capital Management Inc

(1.584%)

since

2025/06/30

19.

Defender Capital, LLC.

(1.4041%)

since

2025/06/30

20.

Citadel Advisors Llc

(1.1202%)

since

2025/06/30

21.

Jupiter Asset Management Limited

(1.0879%)

since

2025/06/30

22.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0727%)

since

2025/07/31

23.

Northern Trust Corp

(1.0347%)

since

2025/06/30

24.

Fidelity Small Cap Index

(1.0134%)

since

2025/06/30

25.

Charles Schwab Investment Management Inc

(0.9571%)

since

2025/06/30

26.

Vanguard Small Cap Growth Index Inv

(0.9519%)

since

2025/07/31

27.

Jupiter Merian Glb Eq AbsRet I USD Acc

(0.8998%)

since

2025/06/30

29.

Two Sigma Investments LLC

(0.8221%)

since

2025/06/30

30.

iShares Russell 2000 Growth ETF

(0.7555%)

since

2025/08/31

31.

Vanguard Tax-Managed Small Cap Adm

(0.611%)

since

2025/07/31

32.

Fidelity Extended Market Index

(0.5428%)

since

2025/07/31

33.

Federated Hermes MDT SCC Institutional

(0.4904%)

since

2025/06/30

34.

Federated Hermes MDT Small Cap Core IS

(0.4904%)

since

2025/06/30

35.

iShares S&P Small-Cap 600 Growth ETF

(0.4889%)

since

2025/08/31

36.

Vanguard Russell 2000 ETF

(0.4804%)

since

2025/07/31

37.

Schwab US Small-Cap ETFâ„¢

(0.472%)

since

2025/08/30

38.

iShares S&P Small-Cap 600 Value ETF

(0.4%)

since

2025/08/31

39.

Principal SmallCap S&P 600 Idx SP

(0.3943%)

since

2025/07/31

40.

State St Russell Sm Cap® Indx SL Cl I

(0.3459%)

since

2025/08/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.0976

Latest Release

Date

2025-09-30

EPS Actual

0.1614

EPS Estimate

0.21

EPS Difference

-0.0486

Surprise Percent

-23.1429%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(8)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.8)
GARP
Fair GARP(6)
Growth
Moderate Growth(4.5)
Momentum
No Momentum(2.5)
Net Net
Possible Net-Net(4)
Quality
Moderate Quality(5.5)
Value
Undervalued(6.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.

STAAR Surgical Company (STAA) Stock Details & Analysis - Finnton | Finnton